Medicine and Dentistry
Systemic Lupus Erythematosus
94%
Lupus Nephritis
50%
Infection
50%
Autoimmune Disease
36%
Cancer Risk
33%
COVID-19
33%
Mycophenolic Acid
29%
Disease
27%
Myositis
22%
Dermatomyositis
16%
Intestinal Pseudoobstruction
16%
Pemphigus vulgaris
16%
Brain Ischemia
16%
Systemic Scleroderma
16%
Anti-Glomerular Basement Membrane Antibody
16%
Immunosuppressive Drug
16%
COVID-19 Vaccine
16%
Pneumomediastinum
16%
Creatinine
16%
Biological Product
16%
Transient Ischemic Attack
16%
Rheumatoid Arthritis
16%
Hydronephrosis
16%
Lupus Erythematosus
16%
Environmental Factor
16%
Immunosuppressive Treatment
15%
Symptom
14%
Malignant Neoplasm
13%
Immune Response
13%
Drug Therapy
12%
Acute Kidney Injury
11%
Autoimmunity
11%
Cancer
11%
Quality of Life
9%
Cytokine
8%
COVID-19 Vaccination
8%
Adverse Event
8%
Clinician
8%
Weakness
8%
Proteinuria
8%
Injury
8%
Biopsy
8%
Hydroxychloroquine
8%
Interstitial Lung Disease
8%
Dyspnea
8%
Apoplexy
8%
Invasive Procedure
8%
Odds Ratio
7%
Disease Modifying Antirheumatic Drug
6%
Patient Population
5%
Keyphrases
Systemic Lupus Erythematosus
100%
Lupus Nephritis
50%
Systemic Lupus Erythematosus Patient
38%
Cancer Risk
33%
Lupus
33%
Mycophenolate Mofetil
29%
New Onset
25%
Dermatomyositis
16%
Common Variable Immunodeficiency
16%
Intestinal Pseudo-obstruction
16%
First-line Therapy
16%
Risk Profile
16%
Coronavirus Disease (COVID)
16%
Mindfulness
16%
Oral Pemphigus Vulgaris
16%
Myositis
16%
Haptoglobin
16%
Single Center
16%
Limited Cutaneous Systemic Sclerosis
16%
COVID-19 Infection
16%
Virus
16%
Anti-glomerular Basement Membrane Antibody
16%
Spontaneous Pneumothorax
16%
Double Positive
16%
Protein-to-creatinine Ratio
16%
Transient Ischemic Attack
16%
Transient Ischemic Stroke
16%
Hydronephrosis
16%
Malignancy
15%
Autoimmune Disease
13%
Environmental Factors
13%
Immunosuppression
12%
Mindfulness Meditation
11%
Acute Kidney Injury
11%
Autoimmunity
11%
Quality of Life
11%
Effective Strategies
8%
Immune Response
8%
First Dose
8%
Older Men
8%
Viral Infection
8%
Infectious Diseases
8%
Lab Values
8%
COVID-19
8%
Chest CT
8%
COVID-19 Vaccination
8%
Humoral Immunity
8%
Trauma-related Infections
8%
Dysmotility
8%
Coronavirus 2
8%
